Cognitive function and its relationship with macular pigment optical density and serum concentrations of its constituent carotenoids

Journal of Alzheimer's Disease

Volumn 48, Issue 1, 2015, Pages 261-277

  Kelly, David ^a   Coen, Robert F ^b   Akuffo, Kwadwo Owusu ^a   Beatty, Stephen ^a,c   Dennison, Jessica ^a   Moran, Rachel ^a   Stack, Jim ^a   Howard, Alan N ^d   Mulcahy, Riona ^e   Nolan, John M ^a  

^a South East Technological University   (Ireland)

^b ST JAMES S HOSPITAL   (Ireland)

^c Institute of Vision Research   (Ireland)

^d Howard Foundation   (United Kingdom)

^e WATERFORD REGIONAL HOSPITAL   (Ireland)

Author keywords

Age related macular degeneration; Biomarker; Cognitive function; Lutein; Macular pigment; Zeaxanthin

Indexed keywords

VISUAL PIGMENT; XANTHOPHYLL; ZEAXANTHIN; CAROTENOID;

ADULT; AGE RELATED MACULAR DEGENERATION; ARTICLE; COGNITION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OPTICAL DENSITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECOGNITION; VERBAL COMMUNICATION; VERBAL MEMORY; VITAMIN BLOOD LEVEL; AGED; BLOOD; COGNITION DISORDERS; COMPLICATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MACULAR DEGENERATION; METABOLISM; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; OPTICAL COHERENCE TOMOGRAPHY; PHOTOMETRY;

ADULT; AGED; CAROTENOIDS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COGNITION DISORDERS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LUTEIN; MACULAR DEGENERATION; MACULAR PIGMENT; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PHOTOMETRY; TOMOGRAPHY, OPTICAL COHERENCE; ZEAXANTHINS;

EID: 84940979929     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-150199     Document Type: Article

References (95)

1. Meagher KA, Thurnham DI, Beatty S, Howard AN, Connolly E, Cummins W, Nolan JM (2013) Serum response to supplemental macular carotenoids in subjects with and without age-related macular degeneration. Br J Nutr 110, 289-300.
2. Bone RA, Landrum JT, Friedes LM, Gomez CM, Kilburn MD, Menendez E, Vidal I, Wang WL (1997) Distribution of lutein and zeaxanthin stereoisomers in the human retina. Exp Eye Res 64, 211-218.
3. Khachik F, Spangler CJ, Smith JC Jr, Canfield LM, Steck A, Pfander H (1997) Identification, quantification, and relative concentrations of carotenoids and their metabolites in human milk and serum. Anal Chem 69, 1873-1881.
4. Widomska J, Subczynski WK (2014) Why has nature chosen lutein and zeaxanthin to protect the retina? J Clin Exp Ophthalmol 5, 326.
5. Beatty S, Koh HH, Henson D, Boulton M (2000) The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 45, 115-134.
6. Trevithick-Sutton CC, Foote CS, Collins M, Trevithick JR (2006) The retinal carotenoids zeaxanthin and lutein scavenge superoxide and hydroxyl radicals: A chemiluminescence and ESR study. Mol Vis 12, 1127-1135.
7. Pintea A, Socaciu C, Rugina DO, Pop R, Bunea A (2011) Xanthophylls protect against induced oxidation in cultured human retinal pigment epithelial cells. J Food Compost Anal 26, 830-836.
8. Junghans A, Sies H, StahlW (2001) Macular pigments lutein and zeaxanthin as blue light filters studied in liposomes. Arch Biochem Biophys 391, 160-164.
9. Bressler NM (2004) Age-related macular degeneration is the leading cause of blindness. JAMA 291, 1900-1901.
10. Loane E, Kelliher C, Beatty S, Nolan JM (2008) The rationale and evidence base for a protective role of macular pigment in age-related maculopathy. Br J Ophthalmol 92, 1163-1168.
11. Chew E, The AREDS2 Study Group (2013) Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: The Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA 309, 2005-2015.
12. Beatty S, ChakravarthyU, Nolan JM, MuldrewKA,Woodside JV, Denny F, Stevenson MR (2013) Secondary outcomes in a clinical trial of carotenoids with coantioxidants versus placebo in early age-related macular degeneration. Ophthalmology 120, 600-606.
13. Sabour-Pickett S, Beatty S, Connolly E, Loughman J, Stack J, Howard A, Klein R, Klein BE, Meuer SM,Myers CE, Akuffo KO, Nolan JM (2014) Supplementation with three different macular carotenoid formulations in patients with early agerelated macular degeneration. Retina 34, 1757-1766.
14. Wang X, Jiang C, Zhang Y, Gong Y, Chen X, ZhangM (2014) Role of lutein supplementation in the management of agerelated macular degeneration: Meta-analysis of randomized controlled trials. Ophthalmic Res 52, 198-205.
15. Huang YM, Yan SF, Ma L, Zou ZY, Xu XR, Dou HL, Lin XM (2013) Serum and macular responses to multiple xanthophyll supplements in patients with early age-related macular degeneration. Nutrition 29, 387-392.
16. Weigert G, Kaya S, Pemp B, Sacu S, Lasta M, Werkmeister RM, Dragostinoff N, Simader C, Garhofer G, Schmidt-Erfurth U, Schmetterer L (2011) Effects of lutein supplementation on macular pigment optical density and visual acuity in patients with age-related macular degeneration. Invest Ophthalmol Vis Sci 52, 8174-8178.
17. Ma L, Yan SF, Huang YM, Lu XR, Qian F, Pang HL, Xu XR, Zou ZY, Dong PC, Xiao X, Wang X, Sun TT, Dou HL, Lin XM (2012) Effect of lutein and zeaxanthin on macular pigment and visual function in patients with early age-related macular degeneration. Ophthalmology 119, 2290-2297.
18. Murray IJ, Makridaki M, van der Veen RL, Carden D, Parry NR, Berendschot TT (2013) Lutein supplementation over a one-year period in early AMD might have a mild beneficial effect on visual acuity: The CLEAR study. Invest Ophthalmol Vis Sci 54, 1781-1788.
19. Nolan JM, Loskutova E, Howard AN, Moran R, Mulcahy R, Stack J, Bolger M, Dennison J, Akuffo KO, Owens N, Thurnham DI, Beatty S (2014) Macular pigment, visual function, and macular disease among subjects with Alzheimer's disease: An exploratory study. J Alzheimers Dis 42, 1191-1202.
20. Loughman J, Nolan JM, Howard AN, Connolly E, Meagher K, Beatty S (2012) The impact of macular pigment augmentation on visual performance using different carotenoid formulations. Invest Ophthalmol Vis Sci 53, 7871-7880.
21. Snodderly DM, Brown PK, Delori FC, Auran JD (1984) The macular pigment. 1. Absorbance spectra, localization, and discrimination from other yellow pigments in primate retinas. Invest Ophthalmol Vis Sci 25, 660-673.
22. Loskutova E, Nolan J, Howard A, Beatty S (2013) Macular pigment and its contribution to vision. Nutrients 5, 1962-1969.
23. Hammond BR, Fletcher LM, Roos F, Wittwer J, Schalch W (2014) A double-blind, placebo-controlled study on the effects of lutein and zeaxanthin on photostress recovery, glare disability, and chromatic contrast. Invest Ophthalmol Vis Sci 55, 8583-8589.
24. Liu R, Wang T, Zhang B, Qin L, Wu C, Li Q, Ma L (2015) Lutein and zeaxanthin supplementation and association with visual function in age-related macular degeneration. Invest Ophthalmol Vis Sci 56, 252-258.
25. Hobbs RP, Bernstein PS (2014) Nutrient supplementation for age-related macular degeneration, cataract, and dry eye. J Ophthalmic Vis Res 9, 487-493.
26. Murray IJ, Makridaki M, van der Veen RL, Carden D, Parry NR, Berendschot TT (2013) Lutein supplementation over a one-year period in early AMD might have a mild beneficial effect on visual acuity: The CLEAR study. Invest Ophthalmol Vis Sci 54, 1781-1788.
27. Connolly EE, Beatty S, Loughman J, Howard AN, Louw MS, Nolan JM (2011) Supplementation with all three macular carotenoids: Response, stability, and safety. Invest Ophthalmol Vis Sci 52, 9207-9217.
28. Nolan JM, Stringham JM, Beatty S, Snodderly DM (2008) Spatial profile of macular pigment and its relationship to foveal architecture. Invest Ophthalmol Vis Sci 49, 2134-2142.
29. Thurnham DI, Nolan JM, Howard AN, Beatty S (2014) Macular response to supplementation with differing xanthophyll formulations in subjects with and without age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 253 (8) , 1231-1243.
30. Craft NE, Haitema TB, Garnett KM, Fitch KA, Dorey CK (2004) Carotenoid, tocopherol, and retinol concentrations in elderly human brain. J Nutr Health Aging 8, 156-162.
31. Vishwanathan R, Neuringer M, Snodderly DM, Schalch W, Johnson EJ (2013) Macular lutein and zeaxanthin are related to brain lutein and zeaxanthin in primates. Nutr Neurosci 16, 21-29.
32. Vishwanathan R, Kuchan MJ, Sen S, Johnson EJ (2014) Lutein and preterm infants with decreased concentrations of brain carotenoids. J Pediatr Gastroenterol Nutr 59, 659-665.
33. Johnson EJ (2012) A possible role for lutein and zeaxanthin in cognitive function in the elderly. Am J Clin Nutr 96, 1161S-1165S.
34. Crichton GE, Bryan J, Murphy KJ (2013) Dietary antioxidants, cognitive function and dementia-a systematic review. Plant Foods Hum Nutr 68, 279-292.
35. Nolan JM, Loskutova E, Howard A, Mulcahy R, Moran R, Stack J, Bolger M, Coen RF, Dennison J, Akuffo KO, Owens N, Power R, Thurnham D, Beatty S (2015) The impact of supplemental macular carotenoids in Alzheimer's disease: A randomized clinical trial. J Alzheimers Dis 44, 1157-1169.
36. Rinaldi P, Polidori MC, Metastasio A, Mariani E, Mattioli P, Cherubini A, Catani M, Cecchetti R, Senin U, Mecocci P (2003) Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease. Neurobiol Aging 24, 915-919.
37. Wang W, Shinto L, Connor WE, Quinn JF (2008) Nutritional biomarkers in Alzheimer's disease: The association between carotenoids, n-3 fatty acids, and dementia severity. J Alzheimers Dis 13, 31-38.
38. Johnson EJ, McDonald K, Caldarella SM, Chung HY, Troen AM, Snodderly DM (2008) Cognitive findings of an exploratory trial of docosahexaenoic acid and lutein supplementation in older women. Nutr Neurosci 11, 75-83.
39. Feeney J, Finucane C, Savva GM, Cronin H, Beatty S, Nolan JM, Kenny RA (2013) Low macular pigment optical density is associated with lower cognitive performance in a large, population-based sample of older adults. Neurobiol Aging 34, 2449-2456.
40. Renzi LM, Bovier ER, Hammond BR Jr (2013) A role for the macular carotenoids in visual motor response. Nutr Neurosci 16, 262-268.
41. Renzi LM, Dengler MJ, Puente A, Miller LS, Hammond BR Jr (2014) Relationships between macular pigment optical density and cognitive function in unimpaired and mildly cognitively impaired older adults. Neurobiol Aging 35, 1695-1699.
42. Vishwanathan R, Iannaccone A, Scott TM, Kritchevsky SB, Jennings BJ, Carboni G, Forma G, Satterfield S, Harris T, Johnson KC, Schalch W, Renzi LM, Rosano C, Johnson EJ (2014) Macular pigment optical density is related to cognitive function in older people. Age Ageing 43, 271-275.
43. Akuffo KO, Beatty S, Stack J, Dennison J, O'Regan S, Meagher KA, Peto T, Nolan J (2014) Central Retinal Enrichment Supplementation Trials (CREST) : Design and methodology of the CREST randomized controlled trials. Ophthalmic Epidemiol 21, 111-123.
44. Nolan JM, Loughman J, Akkali MC, Stack J, Scanlon G, Davison P, Beatty S (2011) The impact of macular pigment augmentation on visual performance in normal subjects: COMPASS. Vision Res 51, 459-469.
45. Davis MD, Gangnon RE, Lee LY, Hubbard LD, Klein BE, Klein R, Ferris FL, Bressler SB, Milton RC (2005) The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17. Arch Ophthalmol 123, 1484-1498.
46. Wooten BR, Hammond BR, Land RI, Snodderly DM (1999) A practical method for measuring macular pigment optical density. Invest Ophthalmol Vis Sci 40, 2481-2489.
47. Wooten BR, Hammond BR (2005) Spectral absorbance and spatial distribution of macular pigment using heterochromatic flicker photometry. Optometry Vis Sci 82, 378-386.
48. Loane E, Stack J, Beatty S, Nolan JM (2007) Measurement of macular pigment optical density using two different heterochromatic flicker photometers. Curr Eye Res 32, 555-564.
49. Stringham JM, Hammond BR, Nolan JM, Wooten BR, Mammen A, SmollonW, SnodderlyDM (2008) The utility of using customized heterochromatic flicker photometry (cHFP) to measure macular pigment in patients with age-related macular degeneration. Exp Eye Res 87, 445-453.
50. Delori FC, Goger DG, Hammond BR, Snodderly DM, Burns SA (2001) Macular pigment density measured by autofluorescence spectrometry: Comparison with reflectometry and heterochromatic flicker photometry. J Opt Soc Am A Opt Image Sci Vis 18, 1212-1230.
51. Wustemeyer H, Jahn C, Nestler A, Barth T, Wolf S (2002) A newinstrument for the quantification of macular pigment density: First results in patients with AMD and healthy subjects. Graefes Arch Clin Exp Ophthalmol 240, 666-671.
52. Trieschmann M, Heimes B, Hense HW, Pauleikhoff D (2006) Macular pigment optical density measurement in autofluorescence imaging: Comparison of one-and twowavelength methods. Graefes Arch Clin Exp Ophthalmol 244, 1565-1574.
53. Robbins TW, James M, Owen AM, Sahakian BJ, McInnes L, Rabbitt P (1994) Cambridge Neuropsychological Test Automated Battery (CANTAB) : A factor analytic study of a large sample of normal elderly volunteers. Dementia 5, 266-281.
54. Wild K, Howieson D,Webbe F, Seelye A, Kaye J (2008) Status of computerized cognitive testing in aging: A systematic review. Alzheimers Dement 4, 428-437.
55. Sahakian BJ, Downes JJ, Eagger S, Evenden JL, Levy R, Philpot MP, Roberts AC, Robbins TW (1990) Sparing of attentional relative to mnemonic function in a subgroup of patients with dementia of the Alzheimer type. Neuropsychologia 28, 1197-1213.
56. Sweeney JA, Kmiec JA, Kupfer DJ (2000) Neuropsychologic impairments in bipolar and unipolar mood disorders on the CANTAB neurocognitive battery. Biol Psychiatry 48, 674-684.
57. Cognition Limited (2012) CANTAB Eclipse Test Administration Guide, Cambridge Cognition Limited, Cambridge, UK.
58. Kesse-Guyot E, Andreeva VA, Ducros V, Jeandel C, Julia C, Hercberg S, Galan P (2014) Carotenoid-rich dietary patterns during midlife and subsequent cognitive function. Br J Nutr 111, 915-923.
59. Rafnsson SB, Dilis V, Trichopoulou A (2013) Antioxidant nutrients and age-related cognitive decline: A systematic review of population-based cohort studies. Eur J Nutr 52, 1553-1567.
60. Johnson EJ, Vishwanathan R, Johnson MA, Hausman DB, Davey A, Scott TM, Green RC, Miller LS, Gearing M, Woodard J, Nelson PT, Chung HY, Schalch W, Wittwer J, Poon LW (2013) Relationship between serum and brain carotenoids, alpha-tocopherol, and retinol concentrations and cognitive performance in the oldest old from the Georgia Centenarian Study. J Aging Res 2013, 951786.
61. Vishwanathan R, Neuringer M, Snodderly DM, Schalch W, Johnson EJ (2013) Macular lutein and zeaxanthin are related to brain lutein and zeaxanthin in primates. Nutr Neurosci 16, 21-29.
62. Baldo JV, Schwartz S, Wilkins D, Dronkers NF (2006) Role of frontal versus temporal cortex in verbal fluency as revealed by voxel-based lesion symptom mapping. J Int Neuropsychol Soc 12, 896-900.
63. Richter FR, Yeung N (2015) Corresponding influences of top-down control on task switching and long-term memory. Q J Exp Psychol (Hove) 68, 1124-1147.
64. Juncos-Rabadan O, Pereiro AX, Facal D, Reboredo A, Lojo-Seoane C (2014) Do the Cambridge Neuropsychological Test Automated Battery episodic memory measures discriminate amnestic mild cognitive impairment? Int J Geriatr Psychiatry 29, 602-609.
65. Junkkila J, Oja S, Laine M, Karrasch M (2012) Applicability of the CANTAB-PAL computerized memory test in identifying amnestic mild cognitive impairment and Alzheimer's disease. Dement Geriatr Cogn Disord 34, 83-89.
66. Yonelinas AP, Otten LJ, Shaw KN, RuggMD (2005) Separating the brain regions involved in recollection and familiarity in recognition memory. J Neurosci 25, 3002-3008.
67. Bovier ER, Renzi LM, Hammond BR (2014) A double-blind, placebo-controlled study on the effects of lutein and zeaxanthin on neural processing speed and efficiency. PLoS One 9, e108178.
68. Smith EE, Jonides J (1999) Storage and executive processes in the frontal lobes. Science 283, 1657-1661.
69. Stuss DT (2011) Traumatic brain injury: Relation to executive dysfunction and the frontal lobes. Curr Opin Neurol 24, 584-589.
70. Nolan JM, Stack J, Mellerio J, Godhinio M, O'Donovan O, Beatty S (2006) Monthly consistency of macular pigment optical density and serum concentrations of lutein and zeaxanthin. Curr Eye Res 31, 199-213.
71. Vishwanathan R, Neuringer M, Snodderly DM, Schalch W, Johnson EJ (2012) Macular lutein and zeaxanthin are related to brain lutein and zeaxanthin in primates. Nutr Neurosci 16, 21-29.
72. Johnson EJ, Vishwanathan R, Johnson MA, Hausman DB, Davey A, Scott TM, Green RC, Miller LS, Gearing M, Woodard J, Nelson PT, Chung HY, Schalch W, Wittwer J, Poon LW (2013) Relationship between serum and brain carotenoids, alpha-tocopherol, and retinol concentrations and cognitive performance in the oldest old from the Georgia Centenarian Study. J Aging Res 2013, 951786.
73. Dias IH, Polidori MC, Li L, Weber D, Stahl W, Nelles G, Grune T, Griffiths HR (2014) Plasma levels of HDL and carotenoids are lower in dementia patients with vascular comorbidities. J Alzheimers Dis 40, 399-408.
74. Akbaraly NT, Faure H, Gourlet V, Favier A, Berr C (2007) Plasma carotenoid levels and cognitive performance in an elderly population: Results of the EVA Study. J Gerontol A Biol Sci Med Sci 62, 308-316.
75. Mecocci P, Polidori MC, Cherubini A, Ingegni T, Mattioli P, Catani M, Rinaldi P, Cecchetti R, Stahl W, Senin U, Beal MF (2002) Lymphocyte oxidative DNA damage and plasma antioxidants in Alzheimer disease. Arch Neurol 59, 794-798.
76. Kiko T, NakagawaK, Tsuduki T, Suzuki T, Arai H, Miyazawa T (2012) Significance of lutein in red blood cells of Alzheimer's disease patients. J Alzheimers Dis 28, 593-600.
77. Nolan JM, Feeney J, Kenny RA, Cronin H, O'Regan C, Savva GM, Loughman J, Finucane C, Connolly E, Meagher K, Beatty S (2012) Education is positively associated with macular pigment: The Irish Longitudinal Study on Ageing (TILDA). Invest Ophthalmol Vis Sci 53, 7855-7861.
78. Nolan JM, Stack J, O'Connell E, Beatty S (2007) The relationships between macular pigment optical density and its constituent carotenoids in diet and serum. Invest Ophthalmol Vis Sci 48, 571-582.
79. Nolan JM, Stack J, O' DO, Loane E, Beatty S (2007) Risk factors for age-related maculopathy are associated with a relative lack of macular pigment. Exp Eye Res 84, 61-74.
80. Hammond BR (2014) Lutein and cognition in children. J Nutr Sci 3, 1-2.
81. Mulder KA, Innis SM, Rasmussen BF, Wu BT, Richardson KJ, HasmanD (2014) Plasma lutein concentrations are related to dietary intake, but unrelated to dietary saturated fat or cognition in young children. J Nutr Sci 3, e11.
82. Nakagawa K, Kiko T, Miyazawa T, Sookwong P, Tsuduki T, Satoh A, Miyazawa T (2011) Amyloid beta-induced erythrocytic damage and its attenuation by carotenoids. FEBS Lett 585, 1249-1254.
83. Katayama S, Ogawa H, Nakamura S (2011) Apricot carotenoids possess potent anti-amyloidogenic activity in vitro. J Agric Food Chem 59, 12691-12696.
84. Connolly EE, Beatty S, Thurnham DI, Loughman J, Howard AN, Stack J, Nolan JM (2010) Augmentation of macular pigment following supplementation with all three macular carotenoids: An exploratory study. Curr Eye Res 35, 335-351.
85. Beatty S, Nolan J, Kavanagh H, O'DonovanO (2004) Macular pigment optical density and its relationship with serum and dietary levels of lutein and zeaxanthin. Arch Biochem Biophys 430, 70-76.
86. Chen K, Zhang X, Wei XP, Qu P, Liu YX, Li TY (2009) Antioxidant vitamin status during pregnancy in relation to cognitive development in the first two years of life. Early Hum Dev 85, 421-427.
87. Johnson EJ (2014) Role of lutein and zeaxanthin in visual and cognitive function throughout the lifespan. Nutr Rev 72, 605-612.
88. Flicker L (2010) Modifiable lifestyle risk factors for Alzheimer's disease. J Alzheimers Dis 20, 803-811.
89. Arab L, SabbaghMN (2010) Are certain lifestyle habits associated with lower Alzheimer's disease risk? J Alzheimers Dis 20, 785-794.
90. Rodriguez-Gomez O, Palacio-Lacambra ME, Palasi A, Ruiz-Laza A, Boada-Rovira M (2014) Prevention of Alzheimer's disease: A global challenge for next generation neuroscientists. J Alzheimers Dis 42, S515-S523.
91. Smith AD, Yaffe K (2014) Dementia (including Alzheimer's disease) can be prevented: Statement supported by international experts. J Alzheimers Dis 38, 699-703.
92. Dennison JL, Stack J, Beatty S, Nolan JM (2013) Concordance of macular pigment measurements obtained using customized heterochromatic flicker photometry, dual-wavelength autofluorescence, and single-wavelength reflectance. Exp Eye Res 116, 190-198.
93. Bone RA, Landrum JT, Cains A (1992) Optical-density spectra of the macular pigment in vivo and in vitro. Vis Res 32, 105-110.
94. Hammond BR Jr,Wooten BR, Smollon B (2005) Assessment of the validity of in vivo methods of measuring human macular pigment optical density. Optom Vis Sci 82, 387-404.
95. Kirby ML, Galea M, Loane E, Stack J, Beatty S, Nolan JM (2009) Foveal anatomic associations with the secondary peak and the slope of the macular pigment spatial profile. Invest Ophthalmol Vis Sci 50, 1383-1391.